Statins Benefit Diabetics

Published Online: Friday, August 1, 2003

Statins are among the most widely used medicines in the Western world, but they are not usually prescribed for diabetes, even though diabetics are at higher risk of heart disease and strokes than nondiabetics. Now, a 5-year British study of nearly 6000 patients suggests that a daily dose of simvastatin can cut the risk of a first heart attack or stroke by nearly 25%?even in diabetic patients with relatively low cholesterol levels. Merck & Co, the maker of simvastatin, provided partial funding for the research. According to the lead researcher, although the study looked only at simvas-tatin, rival products from companies such as Pfizer, AstraZeneca, and Bristol-Myers Squibb are expected to work just as well. The study estimates that this regimen could prevent 1 million heart attacks and strokes worldwide each year.

Latest Articles
A pharmacy robber not only left his fingerprints behind at a pharmacy—he also dropped his wallet containing his identification as he made his escape.
Janssen Research and Development LLC has submitted a new drug application to the FDA for canagliflozin and metformin hydrochloride extended release (Invokamet XR).
Treating chronic pulmonary obstructive disease with both inhaled corticosteroids and long-acting bronchodilators remains controversial, but new evidence suggests that this controller combination could reduce mortality risk.
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.
Latest Issues